| Literature DB >> 16001085 |
Edwige Col1, Cécile Caron, Christine Chable-Bessia, Gaelle Legube, Sylvie Gazzeri, Yasuhiko Komatsu, Minoru Yoshida, Monsef Benkirane, Didier Trouche, Saadi Khochbin.
Abstract
HIV-1 transactivator Tat uses cellular acetylation signalling by targeting several cellular histone acetyltransferases (HAT) to optimize its various functions. Although Tip60 was the first HAT identified to interact with Tat, the biological significance of this interaction has remained obscure. We had previously shown that Tat represses Tip60 HAT activity. Here, a new mechanism of Tip60 neutralization by Tat is described, where Tip60 is identified as a substrate for the newly reported p300/CBP-associated E4-type ubiquitin-ligase activity, and Tat uses this mechanism to induce the polyubiquitination and degradation of Tip60. Tip60 targeting by Tat results in a dramatic impairment of the Tip60-dependent apoptotic cell response to DNA damage. These data reveal yet unknown strategies developed by HIV-1 to increase cell resistance to genotoxic stresses and show a role of Tat as a modulator of cellular protein ubiquitination.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16001085 PMCID: PMC1176461 DOI: 10.1038/sj.emboj.7600734
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598